University of Chicago Hematopathology

Topics

• Acute Myeloid Leukemia Research 152
• Lymphoma Diagnosis and Treatment 96
• Histiocytic Disorders and Treatments 27
• Myeloproliferative Neoplasms: Diagnosis and Treatment 25
• Acute Lymphoblastic Leukemia research 24
• Viral-associated cancers and disorders 15
• Cutaneous lymphoproliferative disorders research 14
• Chronic Lymphocytic Leukemia Research 13
• Eosinophilic Disorders and Syndromes 13
• Hematological disorders and diagnostics 9
• Heat shock proteins research 8
• Mast cells and histamine 8

Most cited

1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.

   Blood · 2022 · 2,489 citations · Daniel Arber

2. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults.

   The New England journal of medicine · 2024 · 235 citations · Daniel Arber

3. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia.

   Blood · 2022 · 199 citations · Daniel Arber

4. TP53 mutation defines a unique subgroup within complex karyotype de novo and therapy-related MDS/AML.

   Blood advances · 2022 · 182 citations · Daniel Arber

5. The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.

   American journal of hematology · 2023 · 88 citations · Daniel Arber

6. What have we learned about TP53-mutated acute myeloid leukemia?

   Blood cancer journal · 2024 · 60 citations · Daniel Arber

7. The international consensus classification of eosinophilic disorders and systemic mastocytosis.